Saxagliptin And Metformin Tablet, Film Coated, Extended Release
Product Images NDC 0378-8176

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Saxagliptin And Metformin (NDC 0378-8176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Saxagliptin Hydrochloride Structural Formula (Image 01)

FDA Label Image

Metformin Hydrochloride Structural Formula (Image 02)

FDA Label Image

Figure 1: Mean Change From Baseline In A1c In A Placebo-controlled Trial Of Saxagliptin As Add-on Combination Therapy With Metformin Immediate-release* (Image 03)

FDA Label Image

Figure 2: Cumulative Percent Of Time To First Mace (Image 04)

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 5 mg/500 mg Bottle Label (Image 05)

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 5 mg/1000 mg Bottle Label (Image 06)

FDA Label Image

Saxagliptin And Metformin HCl Extended-release Tablets 2.5 mg/1000 mg Bottle Label (Image 07)